Prelude Therapeutics Incorporated Common Stock (NASDAQ: PRLD) last traded at $6.63, up 2.00% on the session. The quote above updates while this page is open; the figures below are drawn from Prelude Therapeutics Incorporated Common Stock’s own filings and are restated only when a new one is published.
Prelude Therapeutics Incorporated Common Stock trades on NASDAQ under the ticker PRLD. Its market capitalisation is $529.10 million.
Valuation measures for Prelude Therapeutics Incorporated Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $529.10M |
|---|---|
| Enterprise value | $558.40M |
| Price / sales | 23.60 |
| Price / book | 3.96 |
| Beta | 1.96 |
Trailing-twelve-month figures tagged in Prelude Therapeutics Incorporated Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $22.42M |
|---|---|
| Net income (TTM) | -$60.49M |
| EPS (TTM) | -$0.730 |
| Operating margin | -300.56% |
| Return on equity | -45.23% |
| Cash | $26.33M |
Range and volume for PRLD over the past 52 weeks.
| 52-week high | $6.82 |
|---|---|
| 52-week low | $0.981 |
| Volume | 510.1K |
| Average volume | 459.0K |
| Previous close | $6.50 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.